Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-01-04 @ 2:14 PM
Study NCT ID:
NCT00763568
Status:
COMPLETED
Last Update Posted:
2008-10-01
First Post:
2008-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C
Sponsor:
Romark Laboratories L.C.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RM01-3037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Romark Laboratories, L.C.
Old Organization:
Romark Laboratories, L.C.